Auxilium Pharmaceuticals Inc Lowers FY 2012 Guidance-Conference Call

Thursday, 13 Dec 2012 02:10pm EST 

Auxilium Pharmaceuticals Inc announced that for fiscal 2012, it expects total revenues, excluding a one-time gain that the Company going to recognize from the termination of the Pfizer transaction, in the $294 million to $314 million range and expects net income between zero and $5 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $389 million and net income of $65 million for fiscal 2012. 

Company Quote

0.2 +0.60%
21 Nov 2014